pegfilgrastim
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pegfilgrastim-cbqv (Udenyca OnBody) | SOLUTION, SUBCUTANEOUS | 0.6 mg/6 mL | ||||||||||||||
Pegfilgrastim (Neulasta Onpro Kit) | SOLUTION, SUBCUTANEOUS | 10 mg/mL (6 mg/0.6 mL) | ||||||||||||||
Pegfilgrastim-cbqv (Udenyca) | SOLUTION, SUBCUTANEOUS | 10 mg/mL (6 mg/0.6 mL) | ||||||||||||||
Pegfilgrastim-jmbd (Fulphila) | SOLUTION, SUBCUTANEOUS | 10 mg/mL (6 mg/0.6 mL) |
UNC Health
System Formulary Restriction:
Use of Fulphila injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Use of Udenyca injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use) who meet the following criteria:
Use of Neulasta Onpro injection and Udeynca OnBody injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet at least one of the following criteria:
Payer Policy Coverage: Filgrastim and Pegfilgrastim Coverage
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions
Wayne
Wayne Therapeutic Interchange